HeadofLBABioanalysis

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together. Position Summary You will lead the Ligand Binding Assay (LBA) bioanalysis function in the Bioanalytical and Biomarker Platforms (BBP) department in GSK. You will be responsible for the development, validation, and execution of high‑quality bioanalytical assays, ensuring data integrity, regulatory compliance, and timely delivery to project teams for the entire GSK Biopharm portfolio across all therapeutical areas. You will set scientific direction and partner across drug development teams. Your role will combine technical leadership, people development and operational oversight. We value clear decision-making, practical problem solving, and a commitment to patient-centred science. You will have the chance to grow your career, shape bioanalytical strategy, and make an impact that helps get ahead of disease together. Responsibilities - Serve as the head of the LBA PK group, managing a team of 5-6 lab scientists. Oversee workload planning, resource allocation, and work with partners on prioritization across multiple programs. - Drive LBA PK bioanalytical strategy. Ensure assays are aligned with study phase, regulatory expectations, and scientific objectives. - Provide expert leadership in LBA PK assay development, validation, and sample analysis to support early stage clinical programs. - Provide technical support to transfer LBA PK assays